Home › Lupus Nephritis › Pennsylvania › Philadelphia
Lupus Nephritis clinical trials in Philadelphia, PA
7 studies for Lupus Nephritis are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RecruitingPhase 2
- Temple University, Philadelphia
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
RecruitingPhase 2
- Fox Chase Cancer Center- Temple BMT, Philadelphia
VIBRANT: VIB4920 for Active Lupus Nephritis
RecruitingPhase 2
- Temple University, Lewis Katz School of Medicine, Department of Medicine: Nephrology, Philadelphia
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
RecruitingPhase 4
- Rheumatic Disease Associates, Ltd., Willow Grove · 13 mi away
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
- Jefferson Einstein Hospital Philadelphia, Philadelphia
Lupus Nephritis trials in other cities
- New York City, NY10 studies
- Atlanta, GA9 studies
- Chicago, IL9 studies
- Houston, TX8 studies
- Durham, NC8 studies
- San Francisco, CA7 studies
- Boston, MA7 studies
- Miami, FL5 studies
- Aurora, CO5 studies
- St. Louis, MO5 studies
- Dallas, TX4 studies
- Charleston, SC4 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.